Last reviewed · How we verify
intrathcal methotrexate — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
intrathcal methotrexate (intrathcal methotrexate) — Hui Bu.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| intrathcal methotrexate TARGET | intrathcal methotrexate | Hui Bu | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- intrathcal methotrexate CI watch — RSS
- intrathcal methotrexate CI watch — Atom
- intrathcal methotrexate CI watch — JSON
- intrathcal methotrexate alone — RSS
Cite this brief
Drug Landscape (2026). intrathcal methotrexate — Competitive Intelligence Brief. https://druglandscape.com/ci/intrathcal-methotrexate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing